Dispatches from a Pandemic: What Johnson & Johnson and AstraZeneca’s problems reveal about the COVID-19 mass-vaccination campaign
‘It was a wise decision to spread the risk. Factories can be hit by a hurricane, run out of a supply, or be hit by contamination that forces them to shut down.’
